Table of Contents 1 Hepatitis C Treatment Market Overview 1.1 Product Overview and Scope of Hepatitis C Treatment 1.2 Classification of Hepatitis C Treatment by Types 1.2.1 Global Hepatitis C Treatment Revenue Comparison by Types (2017-2023) 1.2.2 Global Hepatitis C Treatment Revenue Market Share by Types in 2017 1.2.3 HCV Protease Inhibitors 1.2.4 HCV Polymerase Inhibitors 1.2.5 HCV NS5A Inhibitors 1.2.6 Combination Therapy 1.2.7 Interferon and Antiviral 1.2.8 Others 1.3 Global Hepatitis C Treatment Market by Application 1.3.1 Global Hepatitis C Treatment Market Size and Market Share Comparison by Applications (2013-2023) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Home Care 1.4 Global Hepatitis C Treatment Market by Regions 1.4.1 Global Hepatitis C Treatment Market Size (Million USD) Comparison by Regions (2013-2023) 1.4.1 North America (USA, Canada and Mexico) Hepatitis C Treatment Status and Prospect (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Hepatitis C Treatment Status and Prospect (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hepatitis C Treatment Status and Prospect (2013-2023) 1.4.4 South America (Brazil, Argentina, Colombia) Hepatitis C Treatment Status and Prospect (2013-2023) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hepatitis C Treatment Status and Prospect (2013-2023) 1.5 Global Market Size of Hepatitis C Treatment (2013-2023) 2 Manufacturers Profiles 2.1 AbbieVie Inc. 2.1.1 Business Overview 2.1.2 Hepatitis C Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 AbbieVie Inc. Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.2 Bristol-Myers Squibb Company 2.2.1 Business Overview 2.2.2 Hepatitis C Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Bristol-Myers Squibb Company Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.3 F. Hoffmann-La Roche AG 2.3.1 Business Overview 2.3.2 Hepatitis C Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 F. Hoffmann-La Roche AG Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.4 Gilead Sciences Inc. 2.4.1 Business Overview 2.4.2 Hepatitis C Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Gilead Sciences Inc. Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.5 GlaxoSmith Kline Plc. 2.5.1 Business Overview 2.5.2 Hepatitis C Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 GlaxoSmith Kline Plc. Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.6 Janssen Pharmaceuticals Inc. 2.6.1 Business Overview 2.6.2 Hepatitis C Treatment Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Janssen Pharmaceuticals Inc. Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.7 Merck & Co. Inc. 2.7.1 Business Overview 2.7.2 Hepatitis C Treatment Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Merck & Co. Inc. Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.8 Schering AG 2.8.1 Business Overview 2.8.2 Hepatitis C Treatment Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Schering AG Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.9 Vertex Pharmaceuticals 2.9.1 Business Overview 2.9.2 Hepatitis C Treatment Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Vertex Pharmaceuticals Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) 3 Global Hepatitis C Treatment Market Competition, by Players 3.1 Global Hepatitis C Treatment Revenue and Share by Players (2013-2018) 3.2 Market Concentration Rate 3.2.1 Top 5 Hepatitis C Treatment Players Market Share 3.2.2 Top 10 Hepatitis C Treatment Players Market Share 3.3 Market Competition Trend 4 Global Hepatitis C Treatment Market Size by Regions 4.1 Global Hepatitis C Treatment Revenue and Market Share by Regions 4.2 North America Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 4.3 Europe Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 4.5 South America Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 5 North America Hepatitis C Treatment Revenue by Countries 5.1 North America Hepatitis C Treatment Revenue by Countries (2013-2018) 5.2 USA Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 5.3 Canada Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 5.4 Mexico Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 6 Europe Hepatitis C Treatment Revenue by Countries 6.1 Europe Hepatitis C Treatment Revenue by Countries (2013-2018) 6.2 Germany Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 6.3 UK Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 6.4 France Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 6.5 Russia Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 6.6 Italy Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 7 Asia-Pacific Hepatitis C Treatment Revenue by Countries 7.1 Asia-Pacific Hepatitis C Treatment Revenue by Countries (2013-2018) 7.2 China Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 7.3 Japan Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 7.4 Korea Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 7.5 India Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 7.6 Southeast Asia Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 8 South America Hepatitis C Treatment Revenue by Countries 8.1 South America Hepatitis C Treatment Revenue by Countries (2013-2018) 8.2 Brazil Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 8.3 Argentina Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 8.4 Colombia Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 9 Middle East and Africa Revenue Hepatitis C Treatment by Countries 9.1 Middle East and Africa Hepatitis C Treatment Revenue by Countries (2013-2018) 9.2 Saudi Arabia Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 9.3 UAE Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 9.4 Egypt Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 9.5 Nigeria Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 9.6 South Africa Hepatitis C Treatment Revenue and Growth Rate (2013-2018) 10 Global Hepatitis C Treatment Market Segment by Type 10.1 Global Hepatitis C Treatment Revenue and Market Share by Type (2013-2018) 10.2 Global Hepatitis C Treatment Market Forecast by Type (2018-2023) 10.3 HCV Protease Inhibitors Revenue Growth Rate (2013-2023) 10.4 HCV Polymerase Inhibitors Revenue Growth Rate (2013-2023) 10.5 HCV NS5A Inhibitors Revenue Growth Rate (2013-2023) 10.6 Combination Therapy Revenue Growth Rate (2013-2023) 10.7 Interferon and Antiviral Revenue Growth Rate (2013-2023) 10.8 Others Revenue Growth Rate (2013-2023) 11 Global Hepatitis C Treatment Market Segment by Application 11.1 Global Hepatitis C Treatment Revenue Market Share by Application (2013-2018) 11.2 Hepatitis C Treatment Market Forecast by Application (2018-2023) 11.3 Hospital Revenue Growth (2013-2018) 11.4 Clinic Revenue Growth (2013-2018) 11.5 Home Care Revenue Growth (2013-2018) 12 Global Hepatitis C Treatment Market Size Forecast (2018-2023) 12.1 Global Hepatitis C Treatment Market Size Forecast (2018-2023) 12.2 Global Hepatitis C Treatment Market Forecast by Regions (2018-2023) 12.3 North America Hepatitis C Treatment Revenue Market Forecast (2018-2023) 12.4 Europe Hepatitis C Treatment Revenue Market Forecast (2018-2023) 12.5 Asia-Pacific Hepatitis C Treatment Revenue Market Forecast (2018-2023) 12.6 South America Hepatitis C Treatment Revenue Market Forecast (2018-2023) 12.7 Middle East and Africa Hepatitis C Treatment Revenue Market Forecast (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Hepatitis C Treatment Picture Table Product Specifications of Hepatitis C Treatment Table Global Hepatitis C Treatment and Revenue (Million USD) Market Split by Product Type Figure Global Hepatitis C Treatment Revenue Market Share by Types in 2017 Figure HCV Protease Inhibitors Picture Figure HCV Polymerase Inhibitors Picture Figure HCV NS5A Inhibitors Picture Figure Combination Therapy Picture Figure Interferon and Antiviral Picture Figure Others Picture Table Global Hepatitis C Treatment Revenue (Million USD) by Application (2013-2023) Figure Hepatitis C Treatment Revenue Market Share by Applications in 2017 Figure Hospital Picture Figure Clinic Picture Figure Home Care Picture Table Global Market Hepatitis C Treatment Revenue (Million USD) Comparison by Regions 2013-2023 Figure North America Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Europe Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Asia-Pacific Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure South America Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Middle East and Africa Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Global Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2013-2023) Table AbbieVie Inc. Basic Information, Manufacturing Base and Competitors Table AbbieVie Inc. Hepatitis C Treatment Type and Applications Table AbbieVie Inc. Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Company Hepatitis C Treatment Type and Applications Table Bristol-Myers Squibb Company Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) Table F. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors Table F. Hoffmann-La Roche AG Hepatitis C Treatment Type and Applications Table F. Hoffmann-La Roche AG Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Gilead Sciences Inc. Basic Information, Manufacturing Base and Competitors Table Gilead Sciences Inc. Hepatitis C Treatment Type and Applications Table Gilead Sciences Inc. Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) Table GlaxoSmith Kline Plc. Basic Information, Manufacturing Base and Competitors Table GlaxoSmith Kline Plc. Hepatitis C Treatment Type and Applications Table GlaxoSmith Kline Plc. Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Janssen Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors Table Janssen Pharmaceuticals Inc. Hepatitis C Treatment Type and Applications Table Janssen Pharmaceuticals Inc. Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors Table Merck & Co. Inc. Hepatitis C Treatment Type and Applications Table Merck & Co. Inc. Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Schering AG Basic Information, Manufacturing Base and Competitors Table Schering AG Hepatitis C Treatment Type and Applications Table Schering AG Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Vertex Pharmaceuticals Hepatitis C Treatment Type and Applications Table Vertex Pharmaceuticals Hepatitis C Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Global Hepatitis C Treatment Revenue (Million USD) by Players (2013-2018) Table Global Hepatitis C Treatment Revenue Share by Players (2013-2018) Figure Global Hepatitis C Treatment Revenue Share by Players in 2016 Figure Global Hepatitis C Treatment Revenue Share by Players in 2017 Figure Global Top 5 Players Hepatitis C Treatment Revenue Market Share in 2017 Figure Global Top 10 Players Hepatitis C Treatment Revenue Market Share in 2017 Figure Global Hepatitis C Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018) Table Global Hepatitis C Treatment Revenue (Million USD) by Regions (2013-2018) Table Global Hepatitis C Treatment Revenue Market Share by Regions (2013-2018) Figure Global Hepatitis C Treatment Revenue Market Share by Regions (2013-2018) Figure Global Hepatitis C Treatment Revenue Market Share by Regions in 2017 Figure North America Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Europe Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure South America Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Table North America Hepatitis C Treatment Revenue by Countries (2013-2018) Table North America Hepatitis C Treatment Revenue Market Share by Countries (2013-2018) Figure North America Hepatitis C Treatment Revenue Market Share by Countries (2013-2018) Figure North America Hepatitis C Treatment Revenue Market Share by Countries in 2017 Figure USA Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Canada Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Mexico Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Table Europe Hepatitis C Treatment Revenue (Million USD) by Countries (2013-2018) Figure Europe Hepatitis C Treatment Revenue Market Share by Countries (2013-2018) Figure Europe Hepatitis C Treatment Revenue Market Share by Countries in 2017 Figure Germany Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure UK Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure France Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Russia Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Italy Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Table Asia-Pacific Hepatitis C Treatment Revenue (Million USD) by Countries (2013-2018) Figure Asia-Pacific Hepatitis C Treatment Revenue Market Share by Countries (2013-2018) Figure Asia-Pacific Hepatitis C Treatment Revenue Market Share by Countries in 2017 Figure China Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Japan Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Korea Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure India Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Southeast Asia Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Table South America Hepatitis C Treatment Revenue by Countries (2013-2018) Table South America Hepatitis C Treatment Revenue Market Share by Countries (2013-2018) Figure South America Hepatitis C Treatment Revenue Market Share by Countries (2013-2018) Figure South America Hepatitis C Treatment Revenue Market Share by Countries in 2017 Figure Brazil Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Argentina Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Colombia Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Table Middle East and Africa Hepatitis C Treatment Revenue (Million USD) by Countries (2013-2018) Table Middle East and Africa Hepatitis C Treatment Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Hepatitis C Treatment Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Hepatitis C Treatment Revenue Market Share by Countries in 2017 Figure Saudi Arabia Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure UAE Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Egypt Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure Nigeria Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Figure South Africa Hepatitis C Treatment Revenue and Growth Rate (2013-2018) Table Global Hepatitis C Treatment Revenue (Million USD) by Type (2013-2018) Table Global Hepatitis C Treatment Revenue Share by Type (2013-2018) Figure Global Hepatitis C Treatment Revenue Share by Type (2013-2018) Figure Global Hepatitis C Treatment Revenue Share by Type in 2017 Table Global Hepatitis C Treatment Revenue Forecast by Type (2018-2023) Figure Global Hepatitis C Treatment Market Share Forecast by Type (2018-2023) Figure Global HCV Protease Inhibitors Revenue Growth Rate (2013-2018) Figure Global HCV Polymerase Inhibitors Revenue Growth Rate (2013-2018) Figure Global HCV NS5A Inhibitors Revenue Growth Rate (2013-2018) Figure Global Combination Therapy Revenue Growth Rate (2013-2018) Figure Global Interferon and Antiviral Revenue Growth Rate (2013-2018) Figure Global Others Revenue Growth Rate (2013-2018) Table Global Hepatitis C Treatment Revenue by Application (2013-2018) Table Global Hepatitis C Treatment Revenue Share by Application (2013-2018) Figure Global Hepatitis C Treatment Revenue Share by Application (2013-2018) Figure Global Hepatitis C Treatment Revenue Share by Application in 2017 Table Global Hepatitis C Treatment Revenue Forecast by Application (2018-2023) Figure Global Hepatitis C Treatment Market Share Forecast by Application (2018-2023) Figure Global Hospital Revenue Growth Rate (2013-2018) Figure Global Clinic Revenue Growth Rate (2013-2018) Figure Global Home Care Revenue Growth Rate (2013-2018) Figure Global Hepatitis C Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023) Table Global Hepatitis C Treatment Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Hepatitis C Treatment Revenue Market Share Forecast by Regions (2018-2023) Figure North America Hepatitis C Treatment Revenue Market Forecast (2018-2023) Figure Europe Hepatitis C Treatment Revenue Market Forecast (2018-2023) Figure Asia-Pacific Hepatitis C Treatment Revenue Market Forecast (2018-2023) Figure South America Hepatitis C Treatment Revenue Market Forecast (2018-2023) Figure Middle East and Africa Hepatitis C Treatment Revenue Market Forecast (2018-2023)

AbbieVie Inc. Bristol-Myers Squibb Company F. Hoffmann-La Roche AG Gilead Sciences Inc. GlaxoSmith Kline Plc. Janssen Pharmaceuticals Inc. Merck & Co. Inc. Schering AG Vertex Pharmaceuticals